[1] |
Siegel RL, Giaquinto AN, Jemal A.Cancer statistics,2024[J]. CA Cancer J Clin, 2024, 74(1):12-49.DOI: 10.3322/caac.21820.
|
[2] |
Feng RM, Zong YN, Cao SM,et al.Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun (Lond), 2019, 39(1):22.DOI: 10.1186/s40880-019-0368-6.
|
[3] |
Pavlova NN, Zhu J, Thompson CB.The hallmarks of cancer metabolism:still emerging[J]. Cell Metab, 2022, 34(3):355-377.DOI: 10.1016/j.cmet.2022.01.007.
|
[4] |
|
[5] |
Martínez-Reyes I, Chandel NS.Cancer metabolism:looking forward[J]. Nat Rev Cancer, 2021, 21(10):669-680.DOI: 10.1038/s41568-021-00378-6.
|
[6] |
Feng Y, Xiong Y, Qiao T,et al.Lactate dehydrogenase A:a key player in carcinogenesis and potential target in cancer therapy[J]. Cancer Med, 2018, 7(12):6124-6136.DOI: 10.1002/cam4.1820.
|
[7] |
Claps G, Faouzi S, Quidville V,et al.The multiple roles of LDH in cancer[J]. Nat Rev Clin Oncol, 2022, 19(12):749-762.DOI: 10.1038/s41571-022-00686-2.
|
[8] |
Wu HF, Liu H, Zhang ZW,et al.CENPE and LDHA were potential prognostic biomarkers of chromophobe renal cell carcinoma[J]. Eur J Med Res, 2023, 28(1):481.DOI: 10.1186/s40001-023-01449-0.
|
[9] |
Wu C, Zheng C, Chen S,et al.FOXQ1 promotes pancreatic cancer cell proliferation,tumor stemness,invasion and metastasis through regulation of LDHA-mediated aerobic glycolysis[J]. Cell Death Dis, 2023, 14(10):699.DOI: 10.1038/s41419-023-06207-y.
|
[10] |
Chen J, Wu F, Cao Y,et al.The novel role of LDHA/LDHB in the prognostic value and tumor-immune infiltration in clear cell renal cell carcinoma[J]. PeerJ, 2023(11):e15749.DOI: 10.7717/peerj.15749.
|
[11] |
Xiao X, Huang X, Ye F,et al.The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer[J]. Sci Rep, 2016(6):21735.DOI: 10.1038/srep21735.
|
[12] |
Rizwan A, Serganova I, Khanin R,et al.Relationships between LDH-A,lactate,and metastases in 4T1 breast tumors[J]. Clin Cancer Res, 2013, 19(18):5158-5169.DOI: 10.1158/1078-0432.CCR-12-3300.
|
[13] |
Serganova I, Cohen IJ, Vemuri K,et al.LDH-A regulates the tumor microenvironment via HIF-signaling and modulates the immune response[J]. PLoS One, 2018, 13(9):e0203965.DOI: 10.1371/journal.pone.0203965.
|
[14] |
Karami Fath M, Garousi S, Mottahedi M,et al.The role of hypoxia-inducible factors in breast cancer stem cell specification[J]. Pathol Res Pract, 2023(243):154349.DOI: 10.1016/j.prp.2023.154349.
|
[15] |
Yu JM, Sun W, Wang ZH,et al.TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription[J]. Nat Commun, 2019, 10(1):5720.DOI: 10.1038/s41467-019-13700-6.
|
[16] |
Brooks MD, Burness ML, Wicha MS.Therapeutic implications of cellular heterogeneity and plasticity in breast cancer[J]. Cell Stem Cell, 2015, 17(3):260-271.DOI: 10.1016/j.stem.2015.08.014.
|
[17] |
Wang S, Ma L, Wang Z,et al.Lactate dehydrogenase-a (LDH-A) preserves cancer stemness and recruitment of tumor-associated macrophages to promote breast cancer progression[J]. Front Oncol, 2021(11):654452.DOI: 10.3389/fonc.2021.654452.
|
[18] |
Allison SJ, Knight JR, Granchi C,et al.Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways[J]. Oncogenesis, 2014, 3(5):e102.DOI: 10.1038/oncsis.2014.16.
|
[19] |
Chung TW, Kim EY, Han CW,et al.Machilin a inhibits tumor growth and macrophage M2 polarization through the reduction of lactic acid[J]. Cancers (Basel), 2019, 11(7).DOI: 10.3390/cancers11070963.
|
[20] |
Le A, Cooper CR, Gouw AM,et al.Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression[J]. Proc Natl Acad Sci U S A, 2010, 107(5):2037-2042.DOI: 10.1073/pnas.0914433107.
|
[21] |
Wang S, Yu G, Wang Z,et al.Enhanced antitumor efficacy by a cascade of reactive oxygen species generation and drug release[J]. Angew Chem Int Ed Engl, 2019, 58(41):14758-14763.DOI: 10.1002/anie.201908997.
|
[22] |
Wang ZY, Loo TY, Shen JG,et al.LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis[J]. Breast Cancer Res Treat, 2012, 131(3):791-800.DOI: 10.1007/s10549-011-1466-6.
|
[23] |
|
[24] |
|
[25] |
Feng R, Morine Y, Ikemoto T,et al.Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction[J]. Cell Commun Signal, 2018, 16(1):54.DOI: 10.1186/s12964-018-0262-x.
|
[26] |
Chen P, Zuo H, Xiong H,et al.Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis[J]. Proc Natl Acad Sci U S A, 2017, 114(3):580-585.DOI: 10.1073/pnas.1614035114.
|
[27] |
Brand A, Singer K, Koehl GE,et al.LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells[J]. Cell Metab, 2016, 24(5):657-671.DOI: 10.1016/j.cmet.2016.08.011.
|
[28] |
丁振罗.LDHA、MCT4和B7-H3在三阴性乳腺癌新辅助化疗疗效评价中的临床意义[D] .南昌:南昌大学医学部,2023.
|
[29] |
Long Y, Gao Z, Hu X, et al. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma[J]. Cancer Med, 2018, 7(9):4690-4700.DOI: 10.1002/cam4.1713.
|
[30] |
Colegio OR, Chu NQ, Szabo AL,et al.Functional polarization of tumour-associated macrophages by tumour-derived lactic acid[J]. Nature, 2014, 513(7519):559-563.DOI: 10.1038/nature13490.
|
[31] |
Qian BZ, Li J, Zhang H,et al.CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J]. Nature, 2011, 475(7355):222-225.DOI: 10.1038/nature10138.
|
[32] |
Husain Z, Huang Y, Seth P,et al.Tumor-derived lactate modifies antitumor immune response:effect on myeloid-derived suppressor cells and NK cells[J]. J Immunol, 2013, 191(3):1486-1495.DOI: 10.4049/jimmunol.1202702.
|
[33] |
Fischer K, Hoffmann P, Voelkl S,et al.Inhibitory effect of tumor cell-derived lactic acid on human T cells[J]. Blood, 2007, 109(9):3812-3819.DOI: 10.1182/blood-2006-07-035972.
|
[34] |
Jin L, Chun J, Pan C,et al.Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis[J]. Oncogene, 2017, 36(27):3797-3806.DOI: 10.1038/onc.2017.6.
|
[35] |
Wu Z, Wu J, Zhao Q,et al.Emerging roles of aerobic glycolysis in breast cancer[J]. Clin Transl Oncol, 2020, 22(5):631-646.DOI: 10.1007/s12094-019-02187-8.
|
[36] |
Chen X, Luo R, Zhang Y,et al.Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer[J]. Nat Commun, 2022, 13(1):7160.DOI: 10.1038/s41467-022-34702-x.
|
[37] |
de la Cruz-López KG, Castro-Muñoz LJ, Reyes-Hernández DO,et al.Lactate in the regulation of tumor microenvironment and therapeutic approaches[J]. Front Oncol, 2019(9):1143.DOI: 10.3389/fonc.2019.01143.
|
[38] |
Giatromanolaki A, Gkegka AG, Pouliliou S,et al.Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis[J]. Breast Cancer Res Treat, 2022, 194(1):13-23.DOI: 10.1007/s10549-022-06609-0.
|
[39] |
Zagami P, Carey LA. Triple negative breast cancer:pitfalls and progress[J]. NPJ Breast Cancer, 2022, 8(1):95.DOI: 10.1038/s41523-022-00468-0.
|
[40] |
Doyen J, Trastour C, Ettore F,et al.Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome[J]. Biochem Biophys Res Commun, 2014, 451(1):54-61.DOI: 10.1016/j.bbrc.2014.07.050.
|
[41] |
Liu Q, Guan C, Liu C,et al.Targeting hypoxia-inducible factor-1alpha:a new strategy for triple-negative breast cancer therapy[J]. Biomed Pharmacother, 2022(156):113861.DOI: 10.1016/j.biopha.2022.113861.
|
[42] |
Brown JE, Cook RJ, Lipton A,et al.Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer:a retrospective analysis in bisphosphonate-treated patients[J]. Clin Cancer Res, 2012, 18(22):6348-6355.DOI: 10.1158/1078-0432.CCR-12-1397.
|
[43] |
|
[44] |
Hussien R, Brooks GA.Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines[J]. Physiol Genomics, 2011, 43(5):255-264.DOI: 10.1152/physiolgenomics.00177.2010.
|
[45] |
Gottfried E, Lang SA, Renner K,et al.New aspects of an old drug-diclofenac targets MYC and glucose metabolism in tumor cells[J]. PLoS One, 2013, 8(7):e66987.DOI: 10.1371/journal.pone.0066987.
|
[46] |
Farabegoli F, Vettraino M, Manerba M, et al. Galloflavin, a new lactate dehydrogenase inhibitor,induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways[J]. Eur J Pharm Sci, 2012, 47(4):729-738.DOI: 10.1016/j.ejps.2012.08.012.
|
[47] |
Kim EY, Chung TW, Han CW,et al.A novel lactate dehydrogenase inhibitor,1-(Phenylseleno)-4-(Trifluoromethyl) benzene,suppresses tumor growth through apoptotic cell death[J]. Sci Rep, 2019, 9(1):3969.DOI: 10.1038/s41598-019-40617-3.
|
[48] |
Altinoz MA, Ozpinar A.Oxamate targeting aggressive cancers with special emphasis to brain tumors[J]. Biomed Pharmacother, 2022(147):112686.DOI: 10.1016/j.biopha.2022.112686.
|
[49] |
Das CK, Parekh A, Parida PK,et al.Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer[J]. Biochim Biophys Acta Mol Cell Res, 2019, 1866(6):1004-1018.DOI: 10.1016/j.bbamcr.2019.03.004.
|